subject area of
- A Multicenter Phase II Study of “Adjuvant” Irinotecan Following Resection of Colorectal Hepatic Metastases Journal Articles
- A New Strategy To Improve the Metabolic Stability of Lactone: Discovery of (20S,21S)-21-Fluorocamptothecins as Novel, Hydrolytically Stable Topoisomerase I Inhibitors Journal Articles
- A novel form of ataxia oculomotor apraxia characterized by oxidative stress and apoptosis resistance Journal Articles
- A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancers Journal Articles
- A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers Journal Articles
- CSB Regulates Pathway Choice in Response to DNA Replication Stress Induced by Camptothecin Journal Articles
- CSB interacts with BRCA1 in late S/G2 to promote MRN- and CtIP-mediated DNA end resection Journal Articles
- Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Journal Articles
- Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26 Journal Articles
- Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist Journal Articles
- Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors Journal Articles
- Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells Journal Articles
- Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs Journal Articles
- Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer Conferences
- Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy Journal Articles
- The pharmacogenetics of carboxylesterases: CES1 and CES2 genetic variants and their clinical effect Journal Articles
- VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma Journal Articles